| 2021-11-29 08:30:00 | Aiforia hakee osakkeidensa listausta Nasdaq First North Growth Market Finland -markkinapaikalle | https://view.news.eu.nasdaq.com/view?id=be414b4363b2c683cb93cd6ea7aaa3b2b&lang=fi&src=listed |
| 2021-11-29 08:30:00 | Aiforia applies for its shares to be listed on Nasdaq First North Growth Market Finland | https://view.news.eu.nasdaq.com/view?id=b0bdc36ae39e9a596f608effa490199c2&lang=en&src=listed |
| 2021-12-09 15:30:00 | The final subscription price in Aiforia's IPO is EUR 5.01 per share and the listing will be completed as planned | https://view.news.eu.nasdaq.com/view?id=b52cd10547bc2ad8691cb3544a6349f78&lang=en&src=listed |
| 2021-12-09 15:30:00 | Aiforian listautumisannin lopullinen merkintähinta on 501 euroa osakkeelta ja listautuminen toteutetaan suunnitellusti | https://view.news.eu.nasdaq.com/view?id=b2f1583a898452b73af4d0ecbc6656970&lang=fi&src=listed |
| 2021-12-21 08:00:00 | Aiforia: Vakauttamistoimenpiteitä suoritettu | https://view.news.eu.nasdaq.com/view?id=b5ee89ae86ab1176de7569c1600d91423&lang=fi&src=listed |
| 2021-12-21 08:00:00 | Aiforia: Stabilization measures taken | https://view.news.eu.nasdaq.com/view?id=b8921c7012b97ada19e5d561ea655be86&lang=en&src=listed |
| 2022-01-07 17:40:00 | Aiforia: End of the stabilization period; exercise of over-allotment option and cancellation of treasury shares | https://view.news.eu.nasdaq.com/view?id=b5d6183182a5a37164ea36abef5771f5d&lang=en&src=listed |
| 2022-01-07 17:40:00 | Aiforia: Vakauttamisaika päättynyt; lisäosakeoption toteuttaminen ja omien osakkeiden mitätöinti | https://view.news.eu.nasdaq.com/view?id=bd831a7044e7c27320ec5fa44eb35b4d9&lang=fi&src=listed |
| 2022-01-12 08:00:00 | Aiforia aloittaa yhteistyön Mayo Clinicin kanssa muuttaakseen patologian käytäntöjä tekoälypohjaisilla ratkaisuilla | https://view.news.eu.nasdaq.com/view?id=b7bc9c6dccbfc06ca80fcf16e16dcdc71&lang=fi&src=listed |
| 2022-01-12 08:00:00 | Aiforia launches a collaboration with Mayo Clinic to transform pathology practice with AI-powered solutions | https://view.news.eu.nasdaq.com/view?id=b6204d786638b43930231d1ea5d9e6df1&lang=en&src=listed |
| 2022-01-17 09:00:00 | Aiforia appoints VP of Sales Americas | https://view.news.eu.nasdaq.com/view?id=bca5863777677d7d58893ffb5dd5621f3&lang=en&src=listed |
| 2022-01-17 09:00:00 | Aiforia nimittää VP of Sales Americas | https://view.news.eu.nasdaq.com/view?id=b6cc6501267ee3ee286e30acfb8eb0e2d&lang=fi&src=listed |
| 2022-01-28 08:00:00 | Aiforian hallitus perusti tarkastusvaliokunnan ja palkitsemisvaliokunnan | https://view.news.eu.nasdaq.com/view?id=b553887a1ef7e56d4b74bcbcab93e3f70&lang=fi&src=listed |
| 2022-01-28 08:00:00 | Aiforia's Board of Directors established an Audit Committee and a Remuneration Committee | https://view.news.eu.nasdaq.com/view?id=b5352a1a15b059733ba0574d61389c543&lang=en&src=listed |
| 2022-02-15 08:00:00 | Aiforia allekirjoittaa sopimuksen eteläkorealaisen bioteknologiayrityksen kanssa joka pyrkii tehostamaan lääkekehitysalustaansa tekoälyn avulla | https://view.news.eu.nasdaq.com/view?id=b248e149ceecdf92af8307a3e806ea8b1&lang=fi&src=listed |
| 2022-02-15 08:00:00 | Aiforia signs agreement with South Korean biotech company to augment its novel drug discovery platform with AI | https://view.news.eu.nasdaq.com/view?id=bbcf0293c42ae880f37303702e3da89de&lang=en&src=listed |
| 2022-03-03 08:00:00 | Aiforia Technologies Plc Financial Statement Bulletin for January-December 2021: Towards international growth in the preclinical research and clinical diagnostics markets | https://view.news.eu.nasdaq.com/view?id=bc33f1540aab838c6313fb7efef3dc575&lang=en&src=listed |
| 2022-03-03 08:00:00 | Aiforia Technologies Oyj tilinpäätöstiedote tammi–joulukuu 2021: Kohti kansainvälistä kasvua prekliinisen tutkimuksen ja kliinisen diagnostiikan markkinoilla | https://view.news.eu.nasdaq.com/view?id=bcc8694edbf0620a7608d92d4e6422c8a&lang=fi&src=listed |
| 2022-03-03 08:30:00 | Aiforia Technologies Plc Publishes its Board of Directors’ Report and Financial Statements for 2021 | https://view.news.eu.nasdaq.com/view?id=b526057f77f4824c45e3425573d920464&lang=en&src=listed |
| 2022-03-03 08:30:00 | Aiforia Technologies Oyj:n toimintakertomus ja tilinpäätös vuodelta 2021 on julkaistu | https://view.news.eu.nasdaq.com/view?id=bda27dbc8f0647c0fe1b11c21d25577ac&lang=fi&src=listed |
| 2022-03-17 10:30:00 | Notice to convene Aiforia Technologies Plc's annual general meeting of shareholders | https://view.news.eu.nasdaq.com/view?id=ba8c7a90eee0579a38f58143043b985e2&lang=en&src=listed |
| 2022-03-17 10:30:00 | Kutsu Aiforia Technologies Oyj:n varsinaiseen yhtiökokoukseen | https://view.news.eu.nasdaq.com/view?id=b5d66f7024926821f5d6f741334eb6c84&lang=fi&src=listed |
| 2022-04-05 16:00:00 | Decisions taken by Aiforia Technologies Plc's Annual General Meeting and Board of Directors | https://view.news.eu.nasdaq.com/view?id=b85b98bdaba41032d5c1cd495c7659bb6&lang=en&src=listed |
| 2022-04-05 16:00:00 | Aiforia Technologies Oyj:n varsinaisen yhtiökokouksen ja hallituksen päätökset | https://view.news.eu.nasdaq.com/view?id=b5e6783669a879ea87886293a7d50effd&lang=fi&src=listed |
| 2022-04-20 08:30:00 | Aiforia laajentaa CE-IVD merkittyä kliinisen patologian tuotetarjoamaansa uudella tekoälymallilla rintasyövän diagnostiikkaan | https://view.news.eu.nasdaq.com/view?id=be8c1570d9f42d896a5839c10c3e23ad3&lang=fi&src=listed |
| 2022-04-20 08:30:00 | Aiforia expands its portfolio of CE-IVD marked clinical pathology solutions with new AI model for breast cancer diagnostics | https://view.news.eu.nasdaq.com/view?id=b76331ec663be323cb339493c9712d740&lang=en&src=listed |
| 2022-04-22 08:30:00 | The Board of Directors of Aiforia Technologies Plc decided on two new option rights plans | https://view.news.eu.nasdaq.com/view?id=b0e46c95eb254f4e08ba7b0ae4f576e13&lang=en&src=listed |
| 2022-04-22 08:30:00 | Aiforia Technologies Oyj:n hallitus on päättänyt kahdesta uudesta optio-ohjelmasta | https://view.news.eu.nasdaq.com/view?id=b4236922cf95593f869b31872b9ec4735&lang=fi&src=listed |
| 2022-06-02 17:30:00 | Aiforia Technologies Oyj:n osakkeelle LP-markkinatakaus Lago Kapital Oy:ltä | https://view.news.eu.nasdaq.com/view?id=bc081eed142d272abfa5bd0b08737dd99&lang=fi&src=listed |
| 2022-06-02 17:30:00 | Aiforia Technologies Plc appoints Lago Kapital as Liquidity Provider | https://view.news.eu.nasdaq.com/view?id=bd526676b8c55078a60fbaae4a3689440&lang=en&src=listed |
| 2022-06-13 11:00:00 | Share subscriptions based on stock options 2019 I | https://view.news.eu.nasdaq.com/view?id=b805e5cfbefca8d7ade8ea7ca7a83966c&lang=en&src=listed |
| 2022-06-13 11:00:00 | Osakkeiden merkintä optio-oikeuksilla 2019 I | https://view.news.eu.nasdaq.com/view?id=bbb05aca60897b117f7984c3af97a03df&lang=fi&src=listed |
| 2022-08-25 08:00:00 | Aiforia Technologies Oyj - konsernin puolivuotiskatsaus 1.1.2022-30.6.2022 | https://view.news.eu.nasdaq.com/view?id=bb4cd0c47955318e23de47bf8eb97b142&lang=fi&src=listed |
| 2022-08-25 08:00:00 | Aiforia Technologies Plc Half-year report 1 January-30 June 2022 | https://view.news.eu.nasdaq.com/view?id=b3f1a7bb049c54d1c65b71a17f8f02d9d&lang=en&src=listed |
| 2022-08-25 13:00:00 | Aiforian hallituksen jäsen John Sweeney eroaa hallituksesta | https://view.news.eu.nasdaq.com/view?id=b8c3fac5baadb03c1638aad2707afb07d&lang=fi&src=listed |
| 2022-08-25 13:00:00 | Aiforia's member of the Board of Directors John Sweeney resigns from the board | https://view.news.eu.nasdaq.com/view?id=be3aa43fbe1cc3c668239ce61fa0de818&lang=en&src=listed |
| 2022-10-03 10:30:00 | Osakkeiden merkintä optio-oikeuksilla 2018 I ja 2019 I | https://view.news.eu.nasdaq.com/view?id=b8483b59bdde3f2ef5bce53834f56bd4b&lang=fi&src=listed |
| 2022-10-03 10:30:00 | Share subscriptions based on stock options 2018 I and 2019 I | https://view.news.eu.nasdaq.com/view?id=b93222588b2b8dea4a393c3d189a2374c&lang=en&src=listed |
| 2022-10-14 09:30:00 | Change in Aiforia Technologies Plc's Management Team | https://view.news.eu.nasdaq.com/view?id=bc41b3b8c978da9bbfd9131fe1eae3460&lang=en&src=listed |
| 2022-10-14 09:30:00 | Muutos Aiforia Technologies Oyj:n johtoryhmässä | https://view.news.eu.nasdaq.com/view?id=b6d6173f0abfb41529c28efea16615516&lang=fi&src=listed |
| 2022-11-24 07:00:00 | Muutos Aiforia Technologies Oyj:n johtoryhmässä | https://view.news.eu.nasdaq.com/view?id=b8e0b7ac54c6c945dc149675bc2ebf9cf&lang=fi&src=listed |
| 2022-11-24 07:00:00 | Change in Aiforia Technologies Plc's Management Team | https://view.news.eu.nasdaq.com/view?id=bbb05b643e25d1b5adc166a83cc7b6d9e&lang=en&src=listed |
| 2022-12-02 08:00:00 | Aiforia Technologies Plc's financial reporting and Annual General Meeting in financial year 2023 | https://view.news.eu.nasdaq.com/view?id=bd99a0173b0e4de1b48698422a9f3621f&lang=en&src=listed |
| 2022-12-02 08:00:00 | Aiforia Technologies Oyj:n taloudellinen tiedottaminen ja varsinainen yhtiökokous tilikaudella 2023 | https://view.news.eu.nasdaq.com/view?id=b99b32daacb57c89c2a480cb706d749e3&lang=fi&src=listed |
| 2023-02-07 08:00:00 | Osakkeiden merkintä optio-oikeuksilla 2020 I 2021 I ja 2021 IV | https://view.news.eu.nasdaq.com/view?id=b372354ebee67fbea7e2bd89ad6270cb4&lang=fi&src=listed |
| 2023-02-07 08:00:00 | Share subscriptions based on stock options 2020 I 2021 I and 2021 IV | https://view.news.eu.nasdaq.com/view?id=b3921368c34b03b8add3891b9c2dca9b6&lang=en&src=listed |
| 2023-03-02 08:00:00 | Aiforian tilinpäätöstiedote 2022: Kasvu etenee kliinisen markkinan kehityksen vauhdittamana | https://view.news.eu.nasdaq.com/view?id=b645b2b2520294168daf9da55dc457d64&lang=fi&src=listed |
| 2023-03-02 08:00:00 | Aiforia's Financial Statements Bulletin 2022: Growth continues driven by the development of the clinical market | https://view.news.eu.nasdaq.com/view?id=bb18b43ea2342554cf53fdbd4d195414f&lang=en&src=listed |
| 2023-03-02 08:30:00 | Kutsu Aiforia Technologies Oyj:n varsinaiseen yhtiökokoukseen | https://view.news.eu.nasdaq.com/view?id=b32d5e6ca642a846595d12679e747b0b1&lang=fi&src=listed |
| 2023-03-02 08:30:00 | Notice to the Annual General Meeting of Aiforia Technologies Plc | https://view.news.eu.nasdaq.com/view?id=b8fa31f16658682149530bcbb18f45ac8&lang=en&src=listed |
| 2023-03-09 08:00:00 | Aiforia Technologies Oyj:n toimintakertomus ja tilinpäätös vuodelta 2022 on julkaistu | https://view.news.eu.nasdaq.com/view?id=b94c9729df11a95f4044c1b42359c11c3&lang=fi&src=listed |
| 2023-03-09 08:00:00 | Aiforia Technologies Plc Publishes its Board of Directors' Report and Financial Statements for 2022 | https://view.news.eu.nasdaq.com/view?id=b643348ddccb06754e45b8be429e2a2df&lang=en&src=listed |
| 2023-03-30 17:00:00 | Resolutions of Aiforia Technologies Plc's Annual General Meeting and the constitutive meeting of the Board of Directors | https://view.news.eu.nasdaq.com/view?id=b382c1cb2e9c9d8b1a8ee695037c36fd8&lang=en&src=listed |
| 2023-03-30 17:00:00 | Aiforia Technologies Oyj:n varsinaisen yhtiökokouksen ja hallituksen järjestäytymiskokouksen päätökset | https://view.news.eu.nasdaq.com/view?id=bb01bc92d2d90c2f157943f3f1a21cdaf&lang=fi&src=listed |
| 2023-04-27 11:00:00 | Aiforia has received a funding decision from Business Finland to accelerate the development of AI-assisted software solutions for clinical pathology and drug development | https://view.news.eu.nasdaq.com/view?id=b27ff88f3f2e4e3732cfed56ada0cebd8&lang=en&src=listed |
| 2023-04-27 11:00:00 | Aiforia on saanut Business Finlandilta myönteisen rahoituspäätöksen tekoälyavusteisten ohjelmistoratkaisujen kehityksen vauhdittamiseksi kliinisen patologian ja lääkekehityksen tarpeisiin | https://view.news.eu.nasdaq.com/view?id=b86183c0e32a9804f77d162c2dc682e37&lang=fi&src=listed |
| 2023-05-11 08:00:00 | Osakkeiden merkintä optio-oikeuksilla 2019 I 2020 I ja 2021 I | https://view.news.eu.nasdaq.com/view?id=ba45c1c927619d089f84fc29fbabd58b9&lang=fi&src=listed |
| 2023-05-11 08:00:00 | Share subscriptions based on stock options 2019 I 2020 I and 2021 I | https://view.news.eu.nasdaq.com/view?id=b7a9e72fc54618b0bb768232db7c8772f&lang=en&src=listed |
| 2023-06-29 09:30:00 | Inside information: Aiforia signs a major deal with an Italian Regional Health Authority | https://view.news.eu.nasdaq.com/view?id=b717d43095e3edaf3041165cf4fe2dc86&lang=en&src=listed |
| 2023-06-29 09:30:00 | Sisäpiiritieto: Aiforialle merkittävä sopimus italialaisen sairaanhoitopiirin kanssa | https://view.news.eu.nasdaq.com/view?id=bcf2e8d6d46a0300d754bce9ed6b7346e&lang=fi&src=listed |
| 2023-08-10 09:00:00 | Aiforia to publish Half-Year Financial Report for January-June 2023 on 25 August 2023 | https://view.news.eu.nasdaq.com/view?id=b7b3203aede7efb5c266e8b6763319c19&lang=en&src=listed |
| 2023-08-10 09:00:00 | Aiforia julkaisee 25.8.2023 puolivuosikatsauksen tammi-kesäkuulta 2023 | https://view.news.eu.nasdaq.com/view?id=b0cafd45dc413990a114a90a78694b241&lang=fi&src=listed |
| 2023-08-25 08:00:00 | Aiforia's Half-Year Financial Report January-June 2023: Key openings in the clinical diagnostics market - strong growth in the order book | https://view.news.eu.nasdaq.com/view?id=b8d99f5f804ed9b3a1821f4b87a1d7fed&lang=en&src=listed |
| 2023-08-25 08:00:00 | Aiforian puolivuosikatsaus tammi‒kesäkuu 2023: Merkittäviä avauksia kliinisen diagnostiikan markkinalla - tilauskanta kasvoi vahvasti | https://view.news.eu.nasdaq.com/view?id=bd53884f3baa354f6416e067095c6bdc0&lang=fi&src=listed |
| 2023-12-01 07:30:00 | Aiforia's transition to IFRS reporting | https://view.news.eu.nasdaq.com/view?id=b7cb6d235abb0da31aa8cb9f44c5a0a2f&lang=en&src=listed |
| 2023-12-01 07:30:00 | Aiforia siirtyy IFRS-raportointiin | https://view.news.eu.nasdaq.com/view?id=bb72327cd53db6cfd199c9be0a459bbd2&lang=fi&src=listed |
| 2023-12-01 08:00:00 | Change in Aiforia Technologies Plc's Management Team | https://view.news.eu.nasdaq.com/view?id=b5d25ff5e973949917d30016e7bbfa4ac&lang=en&src=listed |
| 2023-12-01 08:00:00 | Muutos Aiforia Technologies Oyj:n johtoryhmässä | https://view.news.eu.nasdaq.com/view?id=b8db384ae7c9a550fa202bd7c1e6ec1fa&lang=fi&src=listed |
| 2023-12-04 08:00:00 | Aiforia Technologies Plc's financial reporting and Annual General Meeting in financial year 2024 | https://view.news.eu.nasdaq.com/view?id=bcca3b0b5af5165771bb1dcb59f692cca&lang=en&src=listed |
| 2023-12-04 08:00:00 | Aiforia Technologies Oyj:n taloudellinen tiedottaminen ja varsinainen yhtiökokous tilikaudella 2024 | https://view.news.eu.nasdaq.com/view?id=b65cc0e3cae2885ebe30b13838308a35a&lang=fi&src=listed |
| 2023-12-22 08:00:00 | Share subscriptions based on stock options 2016A | https://view.news.eu.nasdaq.com/view?id=ba1d1dcf63a94527ef86b5be0b6992c16&lang=en&src=listed |
| 2023-12-22 08:00:00 | Osakkeiden merkintä optio-oikeuksilla 2016A | https://view.news.eu.nasdaq.com/view?id=b1e4bad2a368bec17b390782b80711502&lang=fi&src=listed |
| 2023-12-27 12:00:00 | Aiforia signs a deal with an Italian hospital in Catania | https://view.news.eu.nasdaq.com/view?id=b4b9dfca2f88d7bb846e34f63c55a9456&lang=en&src=listed |
| 2023-12-27 12:00:00 | Aiforialle sopimus italialaisen sairaalan kanssa Cataniassa | https://view.news.eu.nasdaq.com/view?id=b2e3ded9b6edd73555d4c61d89b7f6ce1&lang=fi&src=listed |
| 2024-01-02 09:00:00 | Aiforia signs a licensing agreement with the Mayo Clinic for an AI model that improves prediction of colorectal cancer recurrence | https://view.news.eu.nasdaq.com/view?id=be666cb1498ec8b150f8b4ebceb5acf23&lang=en&src=listed |
| 2024-01-02 09:00:00 | Aiforia solmii lisensointisopimuksen Mayo Clinicin kanssa kolorektaalisyövän uusiutumisriskiä arvioivasta tekoälymallista | https://view.news.eu.nasdaq.com/view?id=bc446bd678538714713a774795eaaa930&lang=fi&src=listed |
| 2024-01-19 08:30:00 | Aiforia Technologies Plc updates its short and mid-term business targets | https://view.news.eu.nasdaq.com/view?id=bc382576b07fb7e60acc90dfd5cedeef1&lang=en&src=listed |
| 2024-01-19 08:30:00 | Aiforia Technologies Oyj päivittää lyhyen ja keskipitkän aikavälin liiketoimintatavoitteitaan | https://view.news.eu.nasdaq.com/view?id=b185c26e466c92c234c8f807f9d604a81&lang=fi&src=listed |
| 2024-02-15 08:30:00 | Aiforia Technologies Plc: Comparative information on transition to IFRS reporting | https://view.news.eu.nasdaq.com/view?id=bc77925085624fb5f60e0355173b52fcb&lang=en&src=listed |
| 2024-02-26 13:00:00 | Aiforia will publish its Financial Statements Bulletin 2023 on 7 March 2024 | https://view.news.eu.nasdaq.com/view?id=beafd65b3b46c7f144ee4d5da69b98c21&lang=en&src=listed |
| 2024-03-06 08:00:00 | Aiforia releases Aiforia® Studies a pioneering GLP-compliant AI-assisted image analysis workflow for non-clinical histology studies | https://view.news.eu.nasdaq.com/view?id=b2f98836cd00b1aae5ab8f2c7732dd09d&lang=en&src=listed |
| 2024-03-07 08:00:00 | Aiforia Technologies Plc's Financial Statements Bulletin 2023: Steady progress in building on the foundations for future growth | https://view.news.eu.nasdaq.com/view?id=bd2e89dea93434935dc2cc4bc5d77b365&lang=en&src=listed |
| 2024-03-07 08:15:00 | Notice to the Annual General Meeting of Aiforia Technologies Plc | https://view.news.eu.nasdaq.com/view?id=b0f8f1882de0b549f59e293b4a3cf44e0&lang=en&src=listed |
| 2024-03-13 10:30:00 | Aiforia Technologies Plc Publishes its Board of Directors' Report and Financial Statements for 2023 | https://view.news.eu.nasdaq.com/view?id=b7f0ed201c89e05ebae4cd8ce616b830f&lang=en&src=listed |
| 2024-03-27 10:30:00 | Share subscriptions based on stock options 2021 II | https://view.news.eu.nasdaq.com/view?id=b87e2a5acc53f290cbf5c5ee5709c56be&lang=en&src=listed |
| 2024-04-04 14:00:00 | Resolutions of Aiforia Technologies Plc's Annual General Meeting and the constitutive meeting of the Board of Directors | https://view.news.eu.nasdaq.com/view?id=bec2faa362226ee5e2d04f499d5d47bda&lang=en&src=listed |
| 2024-04-09 08:00:00 | Richard Haworth joins Aiforia's Scientific Advisory Board | https://view.news.eu.nasdaq.com/view?id=bdb38ef6f094ba3ff8fa22e1161b767d4&lang=en&src=listed |
| 2024-04-24 08:00:00 | Aiforia signs a contract with a veterinary health company in the US | https://view.news.eu.nasdaq.com/view?id=b91f2d53e52baf6681ec57defa5c11e9a&lang=en&src=listed |
| 2024-05-03 10:00:00 | Aiforia delivers AI-powered digital pathology solutions through Google Cloud Marketplace | https://view.news.eu.nasdaq.com/view?id=b35295f015dc6a61daaa4307c8cb889aa&lang=en&src=listed |
| 2024-05-15 14:30:00 | Aiforia wins a framework agreement to provide AI solutions for Fimlab laboratories in Finland | https://view.news.eu.nasdaq.com/view?id=b216ebff65204b9ea92f6f05fe0ff9fa4&lang=en&src=listed |
| 2024-05-22 17:31:00 | INSIDE INFORMATION: AIFORIA TECHNOLOGIES PLC INTENDS TO CARRY OUT A DIRECTED SHARE ISSUE TO RAISE PRELIMINARILY AT LEAST APPROXIMATELY EUR 7 MILLION BY MEANS OF AN ACCELERATED BOOKBUILDING PROCESS | https://view.news.eu.nasdaq.com/view?id=bf9cb85417666b4ab64739887dc162239&lang=en&src=listed |
| 2024-05-22 21:30:00 | INSIDE INFORMATION: AIFORIA TECHNOLOGIES PLC SUCCESSFULLY COMPLETES NEW SHARE ISSUE OF 2843851 NEW SHARES RAISING EUR 9.95 MILLION | https://view.news.eu.nasdaq.com/view?id=b316b633e33f98f94478d411092e9722c&lang=en&src=listed |
| 2024-05-23 16:00:00 | A total of 2843851 new shares in Aiforia Technologies Plc registered with the trade register | https://view.news.eu.nasdaq.com/view?id=bca8031dcb9a949ed2d3f56b5d7d18784&lang=en&src=listed |
| 2024-05-28 10:00:00 | Aiforia Technologies Plc: Disclosure under Chapter 9 Section 10 of the Securities Market Act (Jukka Tapaninen) | https://view.news.eu.nasdaq.com/view?id=bae4eb73a824e5699c80bd7320fea600e&lang=en&src=listed |
| 2024-05-31 10:30:00 | Aiforia Technologies Plc: Disclosure under Chapter 9 Section 10 of the Securities Market Act (Sto-Rahoitus Oy) | https://view.news.eu.nasdaq.com/view?id=b61685df53200e6aa2f80eee64a9f3dad&lang=en&src=listed |
| 2024-06-06 08:00:00 | Aiforia Technologies Plc: Disclosure under Chapter 9 Section 10 of the Securities Market Act (Ascend Tapio S.a.r.l.) | https://view.news.eu.nasdaq.com/view?id=ba9a0a98aa50f41e103393ec72c049817&lang=en&src=listed |
| 2024-06-14 17:00:00 | Aiforia Technologies Plc: Disclosure under Chapter 9 Section 10 of the Securities Market Act (Shandon Diagnostics Limited) | https://view.news.eu.nasdaq.com/view?id=bb4eaedecb099e9de6ee65c2815e06f83&lang=en&src=listed |
| 2024-06-17 13:30:00 | Aiforia Technologies Plc: Disclosure under Chapter 9 Section 10 of the Securities Market Act (Acme Investments Spf Sarl) | https://view.news.eu.nasdaq.com/view?id=b151ccf711745baebf67ade51bcf2c16f&lang=en&src=listed |
| 2024-07-23 12:00:00 | Aiforia selected to provide AI-assisted diagnostics in the Castile and León region in Spain | https://view.news.eu.nasdaq.com/view?id=b25d73cffe558e01b27e0ec049333f907&lang=en&src=listed |
| 2024-08-01 08:00:00 | Aiforia selected to provide AI solutions for breast and prostate cancer diagnostics for Fimlab Laboratories | https://view.news.eu.nasdaq.com/view?id=b928a7e5955877596c251e36723418bee&lang=en&src=listed |
| 2024-08-16 09:00:00 | Aiforia to publish Half-Year Financial Report for January-June 2024 on August 29 2024 | https://view.news.eu.nasdaq.com/view?id=bdada3676f271d936bd2e88008a831baa&lang=en&src=listed |
| 2024-08-29 08:00:00 | Aiforia's Half-Year Financial Report January-June 2024: Progress in the clinical diagnostics market | https://view.news.eu.nasdaq.com/view?id=b394d25cb18fb13a989b068bb7658891f&lang=en&src=listed |
| 2024-09-03 08:00:00 | Change in Aiforia Technologies Plc's Management Team | https://view.news.eu.nasdaq.com/view?id=bf0f482fc056a26443e30f248438e16ea&lang=en&src=listed |
| 2024-09-05 08:00:00 | AP-HP has selected Aiforia as a partner for AI-assisted pathology image analysis | https://view.news.eu.nasdaq.com/view?id=bcef8d74842f7b856e5ac6a2d2323d383&lang=en&src=listed |
| 2024-09-25 08:00:00 | The Board of Directors of Aiforia Technologies Plc has decided on a new option rights plan | https://view.news.eu.nasdaq.com/view?id=b772600f61ec33ebcac1819013b080f28&lang=en&src=listed |
| 2024-10-07 15:15:00 | Aiforia joins the EU-funded Thera4Care project to advance precision medicine | https://view.news.eu.nasdaq.com/view?id=bdc94d6f53472ac7b6aefb2e1bcb83ba0&lang=en&src=listed |
| 2024-10-08 08:00:00 | Aiforia signs a partnership agreement with Urban Datalab to advance AI-based digital pathology in South Korea | https://view.news.eu.nasdaq.com/view?id=bd06fdc9bcec43fc4fc2b13ea5e751970&lang=en&src=listed |
| 2024-10-17 13:15:00 | Aiforia selected as a vendor for the novel NIH STRIDES Google Marketplace | https://view.news.eu.nasdaq.com/view?id=bde53b1e378227cbc75d723ce17ae7088&lang=en&src=listed |
| 2024-10-25 11:30:00 | Share subscriptions based on stock options 2016A 2018 I and 2020 II | https://view.news.eu.nasdaq.com/view?id=b1d51a25749a514080f669b639a1930b2&lang=en&src=listed |
| 2024-10-29 08:00:00 | Aiforia Technologies Plc's financial reporting and Annual General Meeting in financial year 2025 | https://view.news.eu.nasdaq.com/view?id=b2a1c6ae95679fe46541a0bd4414dff51&lang=en&src=listed |
| 2024-11-04 08:00:00 | Aiforia and Paige form strategic partnership to advance AI integration in pathology laboratories | https://view.news.eu.nasdaq.com/view?id=b3ba580ca29d199901a0f620e2ede1d72&lang=en&src=listed |
| 2024-12-02 13:00:00 | Memorial Hospitals Group in Turkey selects Aiforia as the partner for AI-assisted clinical diagnostics in pathology | https://view.news.eu.nasdaq.com/view?id=bbfb8000d63da5b11521313d5466b05ed&lang=en&src=listed |
| 2025-01-24 14:45:00 | Aiforia selected to provide AI-assisted diagnostic solutions to regional health authorities in Italy | https://view.news.eu.nasdaq.com/view?id=be888996ad0bf8d19983888d942775a53&lang=en&src=listed |
| 2025-02-04 16:30:00 | Aiforia CEO increased shareholding in the company in January | https://view.news.eu.nasdaq.com/view?id=bf54a49b8a4a1d133b4eec0f9ed175335&lang=en&src=listed |
| 2025-02-18 10:15:00 | Share subscriptions based on stock options 2016A | https://view.news.eu.nasdaq.com/view?id=bb757fe7734843703e60c11f377104500&lang=en&src=listed |
| 2025-02-20 09:30:00 | Aiforia secures IVDR certification paving the way for expanded clinical portfolio in Europe | https://view.news.eu.nasdaq.com/view?id=b693046b7ba791bd0e8cfe1402d8df927&lang=en&src=listed |
| 2025-02-24 09:30:00 | Aiforia to publish Financial Statements Bulletin 2024 on March 7 2025 | https://view.news.eu.nasdaq.com/view?id=bbd85d67ed000b5620faccddc9852a384&lang=en&src=listed |
| 2025-03-05 08:00:00 | Aiforia and Orion extend collaboration to preclinical study evaluations | https://view.news.eu.nasdaq.com/view?id=b7eca2c5e59f026de9b59aabfc506bdd4&lang=en&src=listed |
| 2025-03-06 08:30:00 | Aiforia closes a deal with a regional health authority of Sardinia in Italy | https://view.news.eu.nasdaq.com/view?id=bf33884939ba17fc992e1f39683e26e13&lang=en&src=listed |
| 2025-03-07 08:00:00 | Aiforia Technologies Plc's Financial Statements Bulletin for January-December 2024: Aiforia's market position and orderbook strengthened | https://view.news.eu.nasdaq.com/view?id=b15e695f907142643c4d0ae96ad31bbf7&lang=en&src=listed |
| 2025-03-13 08:00:00 | Notice of Aiforia Technologies Plc's Annual General Meeting 2025 | https://view.news.eu.nasdaq.com/view?id=b4b818da7e09f9a154bea27b43bf70112&lang=en&src=listed |
| 2025-03-14 08:00:00 | Aiforia Technologies Plc Publishes its Board of Directors' Report and Financial Statements for 2024 | https://view.news.eu.nasdaq.com/view?id=ba8a5de5c4707a821e2034c1e19b6a9dd&lang=en&src=listed |
| 2025-03-18 08:00:00 | Aiforia expands its global reach through a partnership with Quorum Technologies in Canada | https://view.news.eu.nasdaq.com/view?id=b5e4a5d36a4384b92930ad70d43dd2783&lang=en&src=listed |
| 2025-03-21 08:00:00 | Aiforia and Techcyte announce strategic collaboration to advance AI-powered digital pathology | https://view.news.eu.nasdaq.com/view?id=befd8e8006d83778ef078ab772bb8aaba&lang=en&src=listed |
| 2025-03-21 13:00:00 | Aiforia partners with PathPresenter to accelerate the adoption of digital pathology and AI | https://view.news.eu.nasdaq.com/view?id=b29e0c8a967abd452e497a3bc474e4d4f&lang=en&src=listed |
| 2025-03-24 13:00:00 | Aiforia and USCAP extend collaboration to support eLearning for pathologists | https://view.news.eu.nasdaq.com/view?id=bd5cdd90042060002d1e097592c0780ba&lang=en&src=listed |
| 2025-04-01 08:30:00 | Change in Aiforia Technologies Plc's Management Team | https://view.news.eu.nasdaq.com/view?id=b32a1b0f0e49874065315e2dd8dd6e09c&lang=en&src=listed |
| 2025-04-04 14:00:00 | Resolutions of Aiforia Technologies Plc's Annual General Meeting 2025 | https://view.news.eu.nasdaq.com/view?id=b88675d952c5920de3681cbc890ee87c5&lang=en&src=listed |
| 2025-04-16 08:00:00 | Aiforia Technologies Plc: Share subscriptions based on stock options 2020 II | https://view.news.eu.nasdaq.com/view?id=bc2d73cf80471f8523445014dcfd28ae8&lang=en&src=listed |
| 2025-05-08 14:00:00 | Change in Aiforia Technologies Plc's Management Team | https://view.news.eu.nasdaq.com/view?id=b15c3c48de6b511615723cc71d41ca50c&lang=en&src=listed |
| 2025-05-19 10:00:00 | Aiforia closes a deal with the Nantes University Hospital in France | https://view.news.eu.nasdaq.com/view?id=b9ebbb73bba4aa071114348ae0819015d&lang=en&src=listed |
| 2025-05-26 09:00:00 | Aiforia appoints Richard Doughty as Medical Director | https://view.news.eu.nasdaq.com/view?id=b38fa9625b3d62b6a0a840fc4736b3cbe&lang=en&src=listed |
| 2025-05-27 17:31:00 | Inside information: Aiforia Technologies Plc intends to carry out a directed share issue by means of an accelerated bookbuilding proces | https://view.news.eu.nasdaq.com/view?id=bebc5bf7fec08ea53e4418fee0ecda121&lang=en&src=listed |
| 2025-05-27 22:30:00 | Inside information: Aiforia Technologies Plc successfully completes a directed share issue raising EUR 8 million | https://view.news.eu.nasdaq.com/view?id=be52fc97434533972e3b3e41a00514b48&lang=en&src=listed |
| 2025-05-28 15:00:00 | A total of 2502187 new shares in Aiforia Technologies Plc registered with the Trade Register | https://view.news.eu.nasdaq.com/view?id=bf575cf50e561c3460fc7f10a0adfbec8&lang=en&src=listed |
| 2025-05-29 10:30:00 | Aiforia Technologies Plc: Disclosure under Chapter 9 Section 10 of the Securities Market Act - Ascend Tapio Sarl's holding in Aiforia Technologies Plc | https://view.news.eu.nasdaq.com/view?id=b7265fece8eba44700229631a3dfaaf3d&lang=en&src=listed |
| 2025-05-30 17:00:00 | Aiforia Technologies Plc: Disclosure under Chapter 9 Section 10 of the Securities Market Act - Sto-Rahoitus Oy's holding in Aiforia Technologies Plc | https://view.news.eu.nasdaq.com/view?id=b14a3e94f5fff7de6a4035259cef5e277&lang=en&src=listed |
| 2025-06-24 08:00:00 | Aiforia releases a new CE-IVD-marked clinical AI solution for breast cancer diagnostics | https://view.news.eu.nasdaq.com/view?id=b9ed81f737c9af81dfa24daf359eb2f04&lang=en&src=listed |
| 2025-06-24 17:30:00 | The Board of Directors of Aiforia Technologies Plc decided on new Stock Option Plan | https://view.news.eu.nasdaq.com/view?id=bb1261e4cf951fa90e410bbe55ea8ba9f&lang=en&src=listed |
| 2025-06-25 08:00:00 | Aiforia Technologies Plc: Share subscriptions based on stock options 2016 B 2020 I ja 2021 I | https://view.news.eu.nasdaq.com/view?id=bf4e01d2432ba6f782ad0225ccb802252&lang=en&src=listed |
| 2025-07-09 08:00:00 | Aiforia establishes a subsidiary in France to strengthen its position in the European market | https://view.news.eu.nasdaq.com/view?id=bde81eba71667c4fa6cf36c3d789e2719&lang=en&src=listed |
| 2025-08-14 08:30:00 | Change in Aiforia Technologies Plc's Management Team | https://view.news.eu.nasdaq.com/view?id=b0907c992a6f37459eb424a5e4a433a2c&lang=en&src=listed |
| 2025-08-14 10:00:00 | Aiforia to publish January-June 2025 Half-year Financial Report on August 28 2025 | https://view.news.eu.nasdaq.com/view?id=b4f50a64d9a9875a6aa060173400aaba3&lang=en&src=listed |
| 2025-08-28 08:00:00 | Aiforia's Half-Year Financial Report January-June 2025: Expansion continues driven by commercial and regulatory advancements | https://view.news.eu.nasdaq.com/view?id=b72d4efb2c98ad2ec046d7538735aeced&lang=en&src=listed |
| 2025-09-01 14:00:00 | Aiforia forms strategic alliance with Dedalus to integrate AI into pathology diagnostic workflows | https://view.news.eu.nasdaq.com/view?id=b6202df0c10b58b480d1d8a81085ec823&lang=en&src=listed |
| 2025-09-05 09:30:00 | Aiforia releases a new CE-IVD marked clinical AI solution for lymph node metastasis detection | https://view.news.eu.nasdaq.com/view?id=b2a9d9a45cab5df4ec3bc85395b305f1c&lang=en&src=listed |
| 2025-09-08 14:00:00 | Aiforia honors two AI pioneers in digital pathology at the 37th European Congress of Pathology | https://view.news.eu.nasdaq.com/view?id=be5b90598df8ffc0587eba8f11e40ffe3&lang=en&src=listed |
| 2025-09-09 09:00:00 | Aiforia and Siemens Healthineers partner to expand availability of Aiforia's AI applications across Europe | https://view.news.eu.nasdaq.com/view?id=b76ec20bde50b54fb1ee736ba28adbf26&lang=en&src=listed |
| 2025-10-13 09:00:00 | Aiforia's AI solutions for breast cancer diagnostics implemented at Fimlab Laboratories | https://view.news.eu.nasdaq.com/view?id=b2b462ce5fd2e7aee97c072b0d0708339&lang=en&src=listed |
| 2025-10-22 09:30:00 | Aiforia signs a local agreement with Siemens Healthineers Finland | https://view.news.eu.nasdaq.com/view?id=b7c606b9e9ce4f9bd349ebe994d23d5c4&lang=en&src=listed |
| 2025-10-27 09:30:00 | Aiforia selected by Institut Curie for AI-assisted cancer diagnostics | https://view.news.eu.nasdaq.com/view?id=be3934acf4399d619372f7ca87dffecc2&lang=en&src=listed |
| 2025-10-31 08:00:00 | Inside information: Aiforia initiates change negotiations to improve the company's competitiveness and profitability | https://view.news.eu.nasdaq.com/view?id=bd50fea0da8960449cffa26594ae0143a&lang=en&src=listed |
| 2025-11-18 10:00:00 | Aiforia's change negotiations concluded - measures aimed to enhance company's competitiveness and profitability | https://view.news.eu.nasdaq.com/view?id=b0d6a8bf901f53ebff90c5ad52c3b67c8&lang=en&src=listed |
| 2025-12-10 17:31:00 | Inside information: Aiforia Technologies Plc intends to carry out a directed share issue by means of an accelerated bookbuilding process | https://view.news.eu.nasdaq.com/view?id=bba1193a55d86ba7e284ccdf98d48ac04&lang=en&src=listed |
| 2025-12-10 21:10:00 | Inside information: Aiforia Technologies Plc successfully completes a directed share issue raising EUR 4.2 million | https://view.news.eu.nasdaq.com/view?id=ba410c0df917eaea19ac88abd7a502efd&lang=en&src=listed |
| 2025-12-11 13:15:00 | A total of 2000000 new shares in Aiforia Technologies Plc registered with the Trade Register | https://view.news.eu.nasdaq.com/view?id=b1a6715a87997e58a68bd4512c7dea983&lang=en&src=listed |
| 2025-12-17 08:00:00 | Aiforia launches next-generation AI technology platform | https://view.news.eu.nasdaq.com/view?id=b51afddf1a2899339e2cd8d94eb45f7e5&lang=en&src=listed |
| 2025-12-19 08:00:00 | Aiforia Technologies Plc's financial reporting and Annual General Meeting in 2026 | https://view.news.eu.nasdaq.com/view?id=be0e468da5ffd0ebeb59aedf7be3e1b9f&lang=en&src=listed |
| 2025-12-19 08:30:00 | The Board of Directors of Aiforia Technologies Plc decided on new stock option plan | https://view.news.eu.nasdaq.com/view?id=b40548128e3a99a6104d64375eb825685&lang=en&src=listed |
| 2025-12-22 15:00:00 | Change in Aiforia Technologies Plc's Management Team | https://view.news.eu.nasdaq.com/view?id=b64b4c501b7b3db83879d8a47b7a9062b&lang=en&src=listed |
| 2025-12-30 11:00:00 | Aiforia signs an agreement with a prestigious cancer institute in the United States | https://view.news.eu.nasdaq.com/view?id=b2a0792d75a25e409bfb9db84ff74c88f&lang=en&src=listed |
| 2026-01-20 09:30:00 | Change in Aiforia Technologies Plc's stock option plans | https://view.news.eu.nasdaq.com/view?id=bd5cec30565c1e139fdac048df7d733af&lang=en&src=listed |
| 2026-02-02 09:00:00 | Aiforia releases a new CE-IVD marked AI solution for gastric cancer diagnostics | https://view.news.eu.nasdaq.com/view?id=b6af76f8af595a757dfb5bd3416d404cd&lang=en&src=listed |
| 2026-02-05 07:00:00 | Aiforia Technologies Plc: Share subscriptions based on stock options 2016 A 2019 I and 2021 IV | https://view.news.eu.nasdaq.com/view?id=bd5b2da78a4c3e4c0e5203c2b80f66914&lang=en&src=listed |
| 2026-02-18 08:00:00 | Aiforia to publish Financial Statements Bulletin 2025 on March 6 2026 | https://view.news.eu.nasdaq.com/view?id=b7bbc1a1a42b56f8bfcc3e619dc6e9a65&lang=en&src=listed |
| 2026-03-06 08:00:00 | Aiforia Technologies Plc's Financial Statements Bulletin for January-December 2025 (unaudited): Clinical sector revenue increased 68% in 2025 driven by portfolio expansion and commercial execution | https://view.news.eu.nasdaq.com/view?id=bd7189264eae2cdefd22a83729d02ec59&lang=en&src=listed |
| 2026-03-10 08:00:00 | Notice of Aiforia Technologies Plc's Annual General Meeting 2026 | https://view.news.eu.nasdaq.com/view?id=b4164f6054adf6daf95e406039b3157a7&lang=en&src=listed |
| 2026-03-10 09:00:00 | Aiforia and Proscia partner to accelerate AI-driven digital pathology | https://view.news.eu.nasdaq.com/view?id=b197bd1aab691e208c6c4e6f548b5be27&lang=en&src=listed |
| 2026-03-11 15:00:00 | Aiforia Technologies Plc Publishes its Board of Directors' Report and Financial Statements for 2025 | https://view.news.eu.nasdaq.com/view?id=b6b0ff24914c9d5d13a10d774b1bc694a&lang=en&src=listed |
| 2026-03-17 08:30:00 | Aiforia announces the next generation of its CE-IVD marked Prostate Cancer Biopsy AI solution | https://view.news.eu.nasdaq.com/view?id=b869cb478ce9cc6fdef75eae6aa968a86&lang=en&src=listed |
| 2026-04-02 14:05:00 | Resolutions of Aiforia Technologies Plc's Annual General Meeting 2026 | https://view.news.eu.nasdaq.com/view?id=b89f5ae58d8e2f74cc8cc4bf0e08094af&lang=en&src=listed |
| 2026-04-15 08:00:00 | Notice of Aiforia Technologies Plc's Extraordinary General Meeting 2026 | https://view.news.eu.nasdaq.com/view?id=b91387b0d5d721457fa78c3c2278e3caa&lang=en&src=listed |
| 2026-04-16 11:00:00 | Aiforia has been selected as an AI partner for the PROSTIA project - expands to five new hospitals in Paris | https://view.news.eu.nasdaq.com/view?id=b80b9073303f347cec195a1afb02c316c&lang=en&src=listed |
| 2026-04-16 16:00:00 | Aiforia Technologies Plc: Resolutions of the constitutive meeting of the Board of Directors | https://view.news.eu.nasdaq.com/view?id=b3020fef951d049233cc1c52e018522d8&lang=en&src=listed |
| 2026-04-23 10:00:00 | Aiforia closes a deal with a private diagnostic laboratory in Italy | https://view.news.eu.nasdaq.com/view?id=b35f176e5956198378c0bbbbaf526f55c&lang=en&src=listed |
| 2026-04-24 10:00:00 | Aiforia Technologies Plc: Share subscriptions based on stock options 2016A | https://view.news.eu.nasdaq.com/view?id=ba86cf04cd38394382d037087069c4838&lang=en&src=listed |
| 2026-05-12 12:00:00 | Resolutions of Aiforia Technologies Plc's Extraordinary General Meeting 2026 | https://view.news.eu.nasdaq.com/view?id=bac4cae44590c3c6b2c92b0d33fc7e7fd&lang=en&src=listed |
| 2026-05-18 16:00:00 | Aiforia Technologies Plc: Disclosure under Chapter 9 Section 10 of the Securities Market Act - Mikko Laakkonen's holding in Aiforia Technologies Plc | https://view.news.eu.nasdaq.com/view?id=b54de183111fd459a89add15d20f01cca&lang=en&src=listed |
| 2026-06-15 20:45:00 | Inside information: Aiforia and the European Investment Bank agree upon a non-binding indicative term sheet for an up to EUR 20 million venture debt financing facility | https://view.news.eu.nasdaq.com/view?id=b639ef7229e5197a30d47f8320c6327ad&lang=en&src=listed |
| 2026-06-25 17:31:00 | Inside information: Aiforia Technologies Plc intends to carry out a directed share issue by means of an accelerated bookbuilding process | https://view.news.eu.nasdaq.com/view?id=b8d94e13b2b56249e3ade00cf0ae6a45c&lang=en&src=listed |
| 2026-06-25 21:00:00 | Inside information: Aiforia Technologies Plc successfully completes a directed share issue raising approximately EUR 6.4 million | https://view.news.eu.nasdaq.com/view?id=b8a70b00121c6f8b10d27fb48f2d44842&lang=en&src=listed |
| 2026-06-26 11:15:00 | A total of 3600000 new shares in Aiforia Technologies Plc registered with the Trade Register | https://view.news.eu.nasdaq.com/view?id=bb13666b07346cadded4c74f3103751fc&lang=en&src=listed |
| 2026-06-26 15:20:00 | Aiforia Technologies Plc: Disclosure under Chapter 9 Section 10 of the Securities Market Act (Tuomas Tenkanen/TJT Technologies Oy) | https://view.news.eu.nasdaq.com/view?id=bcea5bee04cb7d4cc35d7f635df6c1157&lang=en&src=listed |
| 2026-07-01 20:00:00 | Aiforia Technologies Plc: Disclosure under Chapter 9 Section 10 of the Securities Market Act (Acme Investments SPF Sarl) | https://view.news.eu.nasdaq.com/view?id=b10615d09acf54687d244b71f0333678c&lang=en&src=listed |
| 2026-07-21 17:40:00 | Inside information profit warning: Aiforia's revenue developed below the estimates during January-June 2026 | https://view.news.eu.nasdaq.com/view?id=b35060cea80f64a900bde56f8b4d972a8&lang=en&src=listed |
| 2026-07-31 17:00:00 | Aiforia and the European Investment Bank have signed an agreement for EUR 20 million venture debt financing | https://view.news.eu.nasdaq.com/view?id=bf0d7a0ce4a7ad75796922814805650e4&lang=en&src=listed |
